8-Hydroxy-2-[2-(3-hydroxy-4-methoxy-phenyl)-vinyl]-quinoline-7-carboxylic acid

ID: ALA37139

PubChem CID: 6475560

Max Phase: Preclinical

Molecular Formula: C19H15NO5

Molecular Weight: 337.33

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1O

Standard InChI:  InChI=1S/C19H15NO5/c1-25-16-9-3-11(10-15(16)21)2-6-13-7-4-12-5-8-14(19(23)24)18(22)17(12)20-13/h2-10,21-22H,1H3,(H,23,24)/b6-2+

Standard InChI Key:  FSLDLBJGAMZARH-QHHAFSJGSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.8672  -10.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5810  -10.8646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2919  -10.4473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2861   -9.6215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5634   -9.2146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8556   -9.6342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1473   -8.4083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1484   -9.2357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4336   -9.6485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4354   -7.9955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7200   -8.4047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7193   -9.2315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0040   -9.6425    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2889   -9.2277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2937   -8.3977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0096   -7.9905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5729   -9.6374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8646   -9.6463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5713   -9.2332    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8653  -10.4728    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4317  -10.4735    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400   -9.2222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9989   -9.2026    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0093  -10.8548    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7208  -10.4372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  1  1  0
 12 13  1  0
  1  2  2  0
 13 14  2  0
  3  4  2  0
 14 15  1  0
  7  8  2  0
 15 16  2  0
 16 11  1  0
 14 17  1  0
  8  9  1  0
  9 12  2  0
  4  5  1  0
 18 19  1  0
 18 20  2  0
  8 18  1  0
 11 10  2  0
  9 21  1  0
 10  7  1  0
 17 22  2  0
 22  6  1  0
  2  3  1  0
  4 23  1  0
  5  6  2  0
  3 24  1  0
 11 12  1  0
 24 25  1  0
M  END

Associated Targets(Human)

PIM1 Tchem Serine/threonine-protein kinase PIM1 (9629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3A Tclin Glycogen synthase kinase-3 (736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem Cyclin-dependent kinase 1/cyclin B1 (1887 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem CDK1/Cyclin A (118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1A1 Tchem Casein kinase I alpha (2581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DYRK2 Tchem Dual-specificity tyrosine-phosphorylation regulated kinase 2 (2095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CLK1 Tchem Dual specificty protein kinase CLK1 (2189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 integrase (9041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dyrk1a Dual-specificity tyrosine-phosphorylation regulated kinase 1A (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 337.33Molecular Weight (Monoisotopic): 337.0950AlogP: 3.52#Rotatable Bonds: 4
Polar Surface Area: 99.88Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.41CX Basic pKa: 2.35CX LogP: 3.99CX LogD: 0.83
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.67Np Likeness Score: 0.15

References

1. Zouhiri F, Mouscadet JF, Mekouar K, Desmaële D, Savouré D, Leh H, Subra F, Le Bret M, Auclair C, d'Angelo J..  (2000)  Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture.,  43  (8): [PMID:10780910] [10.1021/jm990467o]
2. Polanski J, Zouhiri F, Jeanson L, Desmaële D, d'Angelo J, Mouscadet JF, Gieleciak R, Gasteiger J, Le Bret M..  (2002)  Use of the Kohonen neural network for rapid screening of ex vivo anti-HIV activity of styrylquinolines.,  45  (21): [PMID:12361391] [10.1021/jm020845g]
3. Prado-Prado FJ, Martinez de la Vega O, Uriarte E, Ubeira FM, Chou KC, González-Díaz H..  (2009)  Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.,  17  (2): [PMID:19112024] [10.1016/j.bmc.2008.11.075]
4. Sliman F, Blairvacq M, Durieu E, Meijer L, Rodrigo J, Desmaële D..  (2010)  Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase.,  20  (9): [PMID:20363627] [10.1016/j.bmcl.2010.03.061]
5. Leonard JT, Roy K..  (2008)  Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.,  43  (1): [PMID:17452064] [10.1016/j.ejmech.2007.02.021]

Source